The Latest

Indian Drug Manufacturer Zydus Violates FDA Regulations Again

Indian generic drug manufacturer Zydus has history of significantly violating FDA regulations Zydus Lifesciences may have an office in...

Opinion: The FDA should ban imports of unsafe generic drugs now

The FDA has repeatedly cited India’s Aurobindo for unsafe manufacturing practices, but still lets it dominate the U.S. market By Michael...

India Pharma Giant Aurobindo Again Violates FDA Safety Regulations

Aurobindo Pharma continues to violate FDA safety regulations Indian pharmaceutical manufacturer Aurobindo was yet again on the receiving...

Congress Must Hold FDA Commissioner Califf Accountable for Shortages

Americans for Safe Drugs releases list of questions that Members of Congress should ask FDA Commissioner Robert M. Califf

CPA Launches Americans for Safe Drugs

Fighting Against Chinese & Indian Generic Pharmaceutical Manufacturers Exporting Unsafe Products to the U.S.

Zydus hit with trio of FDA observations at Indian injectables plant

India’s Zydus Lifesciences is in the FDA’s crosshairs once again, this time for a trio of unnamed violations at an injectables facility.

America’s Other Health Care Crisis: Generic Medicine Supply Chains

The United States is dangerously dependent on foreign manufacturers—particularly in China and India—for essential, lifesaving generics.

FDA Raises Concerns About China-Developed Drugs

U.S. regulators are poised to tap the brakes on approving dozens of cancer drugs and other new medicines developed in China.